271 related articles for article (PubMed ID: 25815130)
21. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
Hendijani F; Javanmard SH; Sadeghi-aliabadi H
Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
[TBL] [Abstract][Full Text] [Related]
22. Single-Stage Preparation of Human Cartilage Grafts Generated from Bone Marrow-Derived CD271
Petters O; Schmidt C; Henkelmann R; Pieroh P; Hütter G; Marquass B; Aust G; Schulz RM
Stem Cells Dev; 2018 Apr; 27(8):545-555. PubMed ID: 29482445
[TBL] [Abstract][Full Text] [Related]
23. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency.
He H; Nagamura-Inoue T; Tsunoda H; Yuzawa M; Yamamoto Y; Yorozu P; Agata H; Tojo A
Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891
[TBL] [Abstract][Full Text] [Related]
24. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
[TBL] [Abstract][Full Text] [Related]
25. [Comparison between CD271 and CD133 used for immunomagnetic positive sorting enriching in mesenchymal stem cells from bone marrow].
Lin W; Tang XM; Kong Y; Wang H; Liu KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):333-8. PubMed ID: 18426660
[TBL] [Abstract][Full Text] [Related]
26. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity.
Anzalone R; Lo Iacono M; Corrao S; Magno F; Loria T; Cappello F; Zummo G; Farina F; La Rocca G
Stem Cells Dev; 2010 Apr; 19(4):423-38. PubMed ID: 19958166
[TBL] [Abstract][Full Text] [Related]
27. Significance of CD271 in bone marrow mesenchymal stem cells--changes by cryopreservation.
Aoyagi K; Yamazaki Y; Matsuo A; Shimakura Y; Takeda A; Uchinuma E
J Craniofac Surg; 2010 May; 21(3):666-78. PubMed ID: 20485027
[TBL] [Abstract][Full Text] [Related]
28. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors.
Bhonde RR; Sheshadri P; Sharma S; Kumar A
Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096
[TBL] [Abstract][Full Text] [Related]
29. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
[TBL] [Abstract][Full Text] [Related]
30. Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue.
Quirici N; Scavullo C; de Girolamo L; Lopa S; Arrigoni E; Deliliers GL; Brini AT
Stem Cells Dev; 2010 Jun; 19(6):915-25. PubMed ID: 19929314
[TBL] [Abstract][Full Text] [Related]
31. Adipogenic potential in human mesenchymal stem cells strictly depends on adult or foetal tissue harvest.
Ragni E; Viganò M; Parazzi V; Montemurro T; Montelatici E; Lavazza C; Budelli S; Vecchini A; Rebulla P; Giordano R; Lazzari L
Int J Biochem Cell Biol; 2013 Nov; 45(11):2456-66. PubMed ID: 23942228
[TBL] [Abstract][Full Text] [Related]
32. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers.
La Rocca G; Anzalone R; Corrao S; Magno F; Loria T; Lo Iacono M; Di Stefano A; Giannuzzi P; Marasà L; Cappello F; Zummo G; Farina F
Histochem Cell Biol; 2009 Feb; 131(2):267-82. PubMed ID: 18836737
[TBL] [Abstract][Full Text] [Related]
33. Adventage of mesenchymal stem cells (MSC) expansion directly from purified bone marrow CD105+ and CD271+ cells.
Jarocha D; Lukasiewicz E; Majka M
Folia Histochem Cytobiol; 2008; 46(3):307-14. PubMed ID: 19056534
[TBL] [Abstract][Full Text] [Related]
34. Human Wharton's Jelly Mesenchymal Stem Cells Show Unique Gene Expression Compared with Bone Marrow Mesenchymal Stem Cells Using Single-Cell RNA-Sequencing.
Barrett AN; Fong CY; Subramanian A; Liu W; Feng Y; Choolani M; Biswas A; Rajapakse JC; Bongso A
Stem Cells Dev; 2019 Feb; 28(3):196-211. PubMed ID: 30484393
[TBL] [Abstract][Full Text] [Related]
35. High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sources.
Amati E; Perbellini O; Rotta G; Bernardi M; Chieregato K; Sella S; Rodeghiero F; Ruggeri M; Astori G
Stem Cell Res Ther; 2018 Jan; 9(1):10. PubMed ID: 29338788
[TBL] [Abstract][Full Text] [Related]
36. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment.
De Bruyn C; Najar M; Raicevic G; Meuleman N; Pieters K; Stamatopoulos B; Delforge A; Bron D; Lagneaux L
Stem Cells Dev; 2011 Mar; 20(3):547-57. PubMed ID: 20923277
[TBL] [Abstract][Full Text] [Related]
37. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
38. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells.
Subramanian A; Shu-Uin G; Kae-Siang N; Gauthaman K; Biswas A; Choolani M; Bongso A; Chui-Yee F
J Cell Biochem; 2012 Jun; 113(6):1886-95. PubMed ID: 22234854
[TBL] [Abstract][Full Text] [Related]
39. Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research.
Frausin S; Viventi S; Verga Falzacappa L; Quattromani MJ; Leanza G; Tommasini A; Valencic E
Acta Histochem; 2015; 117(4-5):329-38. PubMed ID: 25747736
[TBL] [Abstract][Full Text] [Related]
40. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.
Lee S; Park BJ; Kim JY; Jekarl D; Choi HY; Lee SY; Kim M; Kim Y; Park MS
Cytotherapy; 2015 Dec; 17(12):1723-31. PubMed ID: 26589753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
